Atara Biotherapeutics Inc (ATRA)
0.69
-0.01
(-1.40%)
USD |
NASDAQ |
Apr 26, 16:00
0.6911
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Gross Profit Margin (Quarterly): 25.68% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 25.68% |
September 30, 2023 | -22.31% |
Date | Value |
---|---|
June 30, 2023 | -202.5% |
March 31, 2023 | 82.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-202.5%
Minimum
Jun 2023
82.38%
Maximum
Mar 2023
-29.19%
Average
1.69%
Median
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 48.70% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -2.82K% |
Return on Assets | -107.9% |
Return on Invested Capital | -2.82K% |
Profit Margin (Quarterly) | -1.42K% |
Operating Margin (Quarterly) | -1.41K% |
Return on Net Operating Assets | -312.4% |